- Home
- CFFI vs RPID Comparison
CFFI vs RPID Comparison
Compare CFFI & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CFFI | RPID |
|---|---|---|
| Founded | 1927 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 236.4M | 204.3M |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CFFI | RPID |
|---|---|---|
| Price | $72.85 | $4.12 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 1.9K | ★ 133.0K |
| Earning Date | 01-01-0001 | 04-02-2026 |
| Dividend Yield | ★ 2.53% | N/A |
| EPS Growth | ★ 37.94 | 11.48 |
| EPS | ★ 8.29 | N/A |
| Revenue | ★ $140,841,000.00 | $28,051,000.00 |
| Revenue This Year | N/A | $19.91 |
| Revenue Next Year | N/A | $21.68 |
| P/E Ratio | $8.79 | ★ N/A |
| Revenue Growth | 10.63 | ★ 24.57 |
| 52 Week Low | $53.14 | $1.86 |
| 52 Week High | $80.99 | $4.94 |
Technical Indicators
Market Signals| Indicator | CFFI | RPID |
|---|---|---|
| Relative Strength Index (RSI) | 44.36 | 50.05 |
| Support Level | $66.92 | $2.92 |
| Resistance Level | $72.90 | $4.49 |
| Average True Range (ATR) | 1.33 | 0.28 |
| MACD | -0.56 | -0.01 |
| Stochastic Oscillator | 19.37 | 45.98 |
Price Performance
Historical ComparisonAbout CFFI C&F Financial Corporation
C&F Financial Corp is an American bank holding company. The company through its subsidiaries offers banking and related financial services to both individuals and businesses. It operates in three business activities: Community Banking, Mortgage Banking, and Consumer Finance. It mainly provides a range of lending activities, which include residential mortgage loans, commercial real estate loans, non-prime automobile lending, land acquisition, and development loans, and consumer loans. The company generates maximum of its revenue from the Community Banking segment.
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.